Sanguinarine is a novel VEGF inhibitor involved in the suppression of angiogenesis and cell migration
Authors:
- 20 November 2012
- journal article
- Published by Spandidos Publications in Molecular and Clinical Oncology
- Vol. 1 (2) , 331-336
Abstract
Vascular endothelial growth factor (VEGF) is a main angiogenic factor which is known to be upregulated in lung cancer. In the present study, it was demonstrated that sanguinarine, an alkaloid obtained from the bloodroot plant, markedly repressed the VEGF-induced tube formation of human microvascular endothelial cells (HMVECs) and the migration of human A549 lung cancer cells. Furthermore, sanguinarine decreased VEGF secretion and expression in HMVECs and A549 lung cancer cells in a dose- and time-dependent manner. Additionally, sanguinarine inhibited the activation of serum starvation- and hypoxia-induced VEGF promoter activity. Sanguinarine also inhibited the VEGF-mediated Akt and p38 activation, as well as VE-cadherin protein phosphorylation. To the best of our knowledge, this is the first study demonstrating that VEGF inhibition appears to be an important mechanism involved in the antiangiogenic and anti-invasive activities of sanguinarine in lung cancer treatment.Keywords
This publication has 20 references indexed in Scilit:
- Targeting VEGF in lung cancerExpert Opinion on Therapeutic Targets, 2012
- Molecular mechanisms and clinical applications of angiogenesisNature, 2011
- Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasionThe Prostate, 2011
- Antiangiogenic therapy: impact on invasion, disease progression, and metastasisNature Reviews Clinical Oncology, 2011
- Review: Angiogenesis inhibitors in the treatment of non-small cell lung cancerTherapeutic Advances in Medical Oncology, 2009
- Anti-invasive activity of sanguinarine through modulation of tight junctions and matrix metalloproteinase activities in MDA-MB-231 human breast carcinoma cellsChemico-Biological Interactions, 2009
- SanguinarineCardiovascular Drug Reviews, 2008
- Induction of necrosis and apoptosis to KB cancer cells by sanguinarine is associated with reactive oxygen species production and mitochondrial membrane depolarizationToxicology and Applied Pharmacology, 2007
- Sanguinarine Inhibits VEGF‐Induced Akt PhosphorylationAnnals of the New York Academy of Sciences, 2007
- Suppression of angiogenesis by the plant alkaloid, sanguinarineBiochemical and Biophysical Research Communications, 2004